Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.99
Schlusskurs vom Vortag:
$2.99
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$10.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$5.84
Entero Therapeutics Inc Stock (ENTO) Company Profile
Firmenname
Entero Therapeutics Inc
Sektor
Branche
Telefon
561-589-7020
Adresse
777 YAMATO ROAD, BOCA RATON
Compare ENTO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.00 | 10.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.49 | 118.41B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
759.05 | 80.02B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
706.03 | 43.52B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.42 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
287.33 | 32.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Entero Therapeutics Inc Aktie (ENTO) Neueste Nachrichten
Investment Report: Can Entero Therapeutics Inc expand into new marketsMarket Growth Report & Advanced Technical Analysis Signals - baoquankhu1.vn
Weekly Recap: Is Entero Therapeutics Inc stock influenced by commodity prices2026 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Targets Report: Why is Entero Therapeutics Inc. stock going upMarket Activity Recap & Daily Profit Focused Stock Screening - baoquankhu1.vn
Entero Regains Nasdaq Compliance With Grid AI Acquisition - The Asheville Citizen Times
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - The Sheboygan Press
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid - Gadsden Times
Will Entero Therapeutics Inc. stock attract more institutional investorsJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - Naître et grandir
Gridai Technologies Corp (GRDX) Live Share Price, Invest From India - INDmoney
IBN announces latest episode of the TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp. - marketscreener.com
Entero Therapeutics (GRDX) Institutional Ownership 2026 - MarketBeat
GridAI (GRDX) Unveils Collaboration with Amp Z for AI Data Cente - GuruFocus
GridAI Technologies (GRDX) Targets AI-Driven Power Surge With Real-Time Energy Orchestration - NewMediaWire
GridAI Technologies (NASDAQ: GRDX) Poised at Convergence of Electrification, EV Growth and AI Demand - Digital Journal
GridAI Technologies (NASDAQ: GRDX) Targets AI-Driven Power Surge with Real-Time Energy Orchestration - Financial-News.co.uk
ENTO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Morris County NJ News | Daily Record
GridAI Technologies (NASDAQ: GRDX) Targets the Economics of Electricity as AI Turns Power Into a Strategic Cost - USA Today
GridAI Technologies (GRDX) Poised at Convergence of Electrification, EV Growth and AI Demand - NewMediaWire
Swing Trade: Is Entero Therapeutics Inc likely to announce a buybackWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
GridAI Technologies (GRDX) Stock Analysis Report | Financials & Insights - Benzinga France
GridAI Technologies (NASDAQ: GRDX) Highlights Growth Strategy at Intersection of AI and Power Management - The Globe and Mail
GridAI Technologies (GRDX) Highlights Growth Strategy at Intersection of AI and Power Management - NewMediaWire
Is Entero Therapeutics Inc.’s growth already priced inQuarterly Portfolio Review & AI Forecasted Stock Moves - mfd.ru
Does Entero Therapeutics Inc. have consistent dividend growth2025 Short Interest & Entry and Exit Point Strategies - mfd.ru
Can Entero Therapeutics Inc. stock continue upward trendPortfolio Update Report & Entry Point Confirmation Signals - mfd.ru
Why is Entero Therapeutics Inc. stock going downMarket Performance Recap & Detailed Earnings Play Alerts - mfd.ru
Signal Recap: Why is Entero Therapeutics Inc stock going downTrade Analysis Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Analyst Upgrade: Can Entero Therapeutics Inc expand into new marketsJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
Top Entero Therapeutics (GRDX) Competitors 2026 - MarketBeat
Tim Healy appointed executive chairman at GridAI Technologies By Investing.com - Investing.com Nigeria
Forecast Cut: Why is Entero Therapeutics Inc stock going upMarket Sentiment Review & Real-Time Volume Spike Alerts - baoquankhu1.vn
What are Entero Therapeutics Inc.’s recent SEC filings showingBear Alert & Advanced Swing Trade Entry Alerts - mfd.ru
Update Recap: Is Entero Therapeutics Inc likely to announce a buybackQuarterly Portfolio Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Earnings Update: Is Entero Therapeutics Inc stock undervalued right nowQuarterly Trade Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn
GridAI Technologies (NASDAQ: GRDX) Engages IBN to Support Corporate Communications Strategy - Digital Journal
GridAI Technologies Partners with IBN to Enhance Corporate Communications - Intellectia AI
IBN Initiates Coverage of GridAI Technologies Corp. - The Manila Times
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer - Corpus Christi Caller-Times
GridAI Technologies (NASDAQ: GRDX) Positions Itself at the Operating Layer of a Continuously Managed Electric Grid - Digital Journal
GridAI Technologies (GRDX) Positions Itself at the Operating Layer of a Continuously Managed Electric Grid - NewMediaWire
Whittier Daily News - FinancialContent
GridAI and the New Operating Reality of the Electric Grid - The Globe and Mail
Why the electric grid now needs GridAI-style continuous control to function - Stock Titan
Finanzdaten der Entero Therapeutics Inc-Aktie (ENTO)
Es liegen keine Finanzdaten für Entero Therapeutics Inc (ENTO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):